| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 04/04/2007 | EP1377556B1 Pyrazole derivatives for treating hiv |
| 04/04/2007 | EP1362033B1 Pyridine matrix metalloproteinase inhibitors |
| 04/04/2007 | CN1939903A Mandelic acid derivatives and their use as throbin inhibitors |
| 04/04/2007 | CN1939902A Mandelic acid derivatives and their use as throbin inhibitors |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1308302C Taxol enhancer compounds |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199143 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 03/29/2007 | US20070072872 Treating sexual desire disorders with flibanserin |
| 03/29/2007 | US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 03/29/2007 | US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307173C Pyrimidineamines as angiogenesis modulators |
| 03/27/2007 | US7196096 Substituted amines of spirofuropyridines useful in therapy |
| 03/27/2007 | US7195761 Humanized antibodies that sequester abeta peptide |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192613 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 03/15/2007 | US20070059346 Film comprising therapeutic agents |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | CN1303996C use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
| 03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
| 03/07/2007 | CN1926132A Pyrazole compounds useful as protein kinase inhibitors |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 02/28/2007 | EP1757601A1 Quinoline derivatives and their use in glaucoma and myopia |
| 02/28/2007 | EP1429807B1 Combination of a nsaid and a pde-4 inhibitor |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1916009A Process for preparing amine platinum complexes |
| 02/21/2007 | CN1915429A Combinations of the peroxisome proliferator-activated receptor (ppar) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/15/2007 | US20070037773 Methods and compositions for treating flaviviruses and pestiviruses |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911230A Cancer treatment |
| 02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | CN1907968A Method for making 4-(3,4-dichlorophenoxy)piperidine |
| 02/07/2007 | CN1907289A Prophylactic and therapeutic treatment of infectious and other diseases with mono and disaccharide-based compounds |
| 02/06/2007 | US7173038 Treatment of diseases such as cancer or arthritis |
| 02/01/2007 | US20070027138 Derivatives and analogs of galanthamine |
| 02/01/2007 | US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/24/2007 | EP1126823B1 A process for the preparation of sterile therapeutically acceptable beclomethasone dipropionate |
| 01/24/2007 | CN1900087A Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 01/24/2007 | CN1296043C Use of formula I Rapamycin compound in preparing pharmaceutical composition for treating solid tumor |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/18/2007 | US20070015800 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015756 For therapy of hyperproliferative diseases |
| 01/18/2007 | US20070014766 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/18/2007 | US20070014749 Novel base material for pharmaceutical and/or cosmetic cream (herbal composition for itchy or infected skin) |
| 01/17/2007 | CN1896088A C－芳基葡糖苷sglt2抑制剂 C- aryl glucoside sglt2 inhibitors |
| 01/16/2007 | US7164017 Exhibit electrophysiological activity |
| 01/16/2007 | US7163929 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/10/2007 | CN1894238A Diamine derivatives |
| 01/10/2007 | CN1893977A Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 01/10/2007 | CN1893970A Beta-amyloid-analogue-cell epitop vaccine |
| 01/10/2007 | CN1893941A Fused-ring compounds and use thereof as drugs |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/09/2007 | CA2375372C Mutual prodrugs of amlodipine and atorvastatin |
| 01/09/2007 | CA2294033C Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |
| 12/28/2006 | US20060293239 Treatment and Diagnosis of Insulin-Resistant States |
| 12/27/2006 | EP1736478A1 Methods and compositions for treating flaviviruses and pestiviruses |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/21/2006 | US20060287336 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders |
| 12/20/2006 | CN1879632A Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 12/19/2006 | US7151103 A serotonin receptor antagonists for therapeutic treatment |
| 12/14/2006 | WO2001022972A9 Immunostimulatory nucleic acids |
| 12/13/2006 | EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 12/13/2006 | CN1876653A Zolpidem hemitartrate |
| 12/13/2006 | CN1876652A Zolpidem hemitartrate |
| 12/13/2006 | CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 12/12/2006 | US7148242 N-formyl hydroxylamine compounds, compositions and methods of use |
| 12/12/2006 | US7148206 Methods and compositions for treating flaviviruses and pestiviruses |
| 12/07/2006 | US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38 |
| 12/06/2006 | CN1287774C Composition for inhalation |
| 12/05/2006 | US7144914 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 12/05/2006 | US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/29/2006 | EP1162999B1 Vaccine against Streptococcus pneumoniae |
| 11/29/2006 | CN1869061A Peptidomimetic protease inhibitors |
| 11/28/2006 | US7141607 Topically administering Hydroxamic acid matrix metalloproteinase inhibitors such as batimastat to the eye |
| 11/28/2006 | US7141604 Administering to a patient citalopram or salts to treat hypertension and hypotension |
| 11/23/2006 | US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE |
| 11/23/2006 | US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors |
| 11/16/2006 | US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 11/15/2006 | EP1513800B1 N-benzoylureidocinnamate derivatives, method for production and use thereof |